封面
市場調查報告書
商品編碼
1397024

靜脈導管市場:依產品類型、最終用戶分類:全球機會分析與產業預測,2023-2032 年

IV Catheters Market By Product (18G, 20G, 22G, 24G, Others), By Type (Peripheral IV Catheters, Central Venous Catheters, Others), By End User (Hospitals, Ambulatory Surgical Centers, Others): Global Opportunity Analysis & Industry Forecast, 2023-2032

出版日期: | 出版商: Allied Market Research | 英文 303 Pages | 商品交期: 2-3個工作天內

價格

2022年靜脈導管市值為86億美元,預計到2032年將達到178億美元,2023年至2032年的年複合成長率為7.5%。

靜脈 (IV) 導管,也稱為 IV 光或 IV 插管,是一種用於給藥液體、藥物和血液製品直接注入患者血流的醫療設備。導管通常由一根由生物相容性材料(例如塑膠)製成的細軟性管組成,一端連接有鋒利的針或導管。使用針刺穿靜脈,一旦導管指定,就將針移除,將導管牢固地留在靜脈中。

推動靜脈導管市場成長的主要因素是患有慢性病的人數不斷增加、老年人口不斷增加以及靜脈導管的不斷進步。癌症、糖尿病、心血管疾病和感染疾病等慢性疾病的擴散正在推動靜脈導管的需求。靜脈注射可以直接有效地輸送藥物、液體和營養物質,使其成為慢性病患者的重要治療方式。

目錄

第1章簡介

第 2 章執行摘要

第3章市場概況

  • 市場定義和範圍
  • 主要發現
    • 影響因素
    • 主要投資機會
  • 波特五力分析
  • 市場動態
    • 促進因素
      • 慢性病盛行率上升
      • 手術數量快速增加
      • 靜脈注射裝置的技術進步
    • 抑制因素
      • 併發症的風險
    • 機會
      • 新興國家的成長機會

第4章 導管市場:依產品

  • 概述
  • 18G
  • 20G
  • 22G
  • 24G
  • 其他

第5章 導管市場:依類型

  • 概述
  • 周邊靜脈導管
  • 中央靜脈導管
  • 其他

第6章 IV 導管市場:依最終使用者分類

  • 概述
  • 醫院
  • 門診手術中心
  • 其他

第7章 導管市場:依地區

  • 概述
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 其他
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 馬來西亞
    • 泰國
    • 菲律賓
    • 新加坡
    • 印尼
    • 越南
    • 其他
  • 拉丁美洲/中東/非洲
    • 巴西
    • 沙烏地阿拉伯
    • 南非
    • 其他

第8章 競爭形勢

  • 介紹
  • 關鍵成功策略
  • 10家主要企業產品圖譜
  • 競爭儀表板
  • 競爭熱圖
  • 2022年主要企業定位

第9章 公司簡介

  • AngioDynamics, Inc.
  • Terumo Corporation
  • Teleflex Incorporated
  • ICU Medical Inc.
  • Becton, Dickinson and Company
  • B. Braun SE
  • BL Group of Companies
  • Poly Medicure Ltd.
  • Vygon
  • Nipro Corporation
Product Code: A14420

The IV catheters market was valued at $8.6 billion in 2022 and is estimated to reach $17.8 billion by 2032, exhibiting a CAGR of 7.5% from 2023 to 2032. An intravenous (IV) catheter, also known as an IV line or IV cannula, is a medical device used to administer fluids, medications, or blood products directly into a patient's bloodstream. It consists of a thin, flexible tube typically made of plastic or other biocompatible materials with a sharp needle or catheter at one end. The needle is used to puncture a vein, and once the catheter is in place, the needle is removed, leaving the catheter securely in the vein.

The major factors driving the growth of the IV catheters market are the increase in the number of people suffering from chronic conditions, rise in geriatric population, and continuous advancements in IV catheters. The surge in prevalence of chronic diseases such as cancer, diabetes, cardiovascular disorders, and infectious diseases drives the demand for IV catheters. Intravenous administration allows for the direct and efficient delivery of medications, fluids, and nutrition, making it a crucial treatment method for patients with chronic conditions.

In addition, ongoing technological advancements in IV catheter designs, materials, insertion techniques, and related medical equipment have made IV therapy more efficient, comfortable, and safe, which is expected to drive the market growth. Innovations encourage healthcare providers to utilize IV catheters for a broader range of treatments, further driving the market expansion.

Further, the trend toward home-based healthcare and outpatient services has increased the use of IV catheters outside traditional hospital settings, thereby driving the market growth. Patients with chronic conditions or those requiring post-operative care may receive IV therapy at home, leading to higher demand.

However, the risk of complications and infections and stringent regulatory requirements are the factors that hamper the growth of IV catheters market. The use of intravenous equipment carries a certain degree of risk, including the potential for complications and infections. Improper insertion, handling, or maintenance of IV catheters may lead to catheter-related bloodstream infections (CRBSIs) or other complications such as phlebitis or infiltration, thereby restraining the market growth. However, the growing aging population, increase in surgical procedures, and rise in technological advancements are expected to offer opportunities to the key players of the market.

The IV catheters market is segmented into product, type, end user, and region. By product, the market is classified into 18 G, 20G, 22G, 24 G, and others. By type, the market is classified into peripheral IV catheters, central venous catheters, and others. By end user, the market is classified into hospitals, ambulatory surgical centers, and others. Region-wise, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, Malaysia, Thailand, Philippines, Singapore, Indonesia, Vietnam, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).

Major key players that operate in the global IV catheters market are Becton Dickinson & Company, B Braun SE, AngioDynamics, Inc., Terumo Corporation, Poly Medicure Ltd., Teleflex Incorporated, Vygon, BL Group of Companies, and ICU Medical Inc. Key players operating in the market have adopted acquisition, product launch and others as their key strategies to expand their product portfolio.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the iv catheters market analysis from 2022 to 2032 to identify the prevailing iv catheters market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the iv catheters market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global iv catheters market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Product

  • 18G
  • 20G
  • 22G
  • 24G
  • Others

By Type

  • Others
  • Peripheral IV Catheters
  • Central Venous Catheters

By End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Malaysia
    • Thailand
    • Philippines
    • Singapore
    • Indonesia
    • Vietnam
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • ICU Medical Inc.
    • Terumo Corporation
    • Vygon
    • Becton, Dickinson and Company
    • Nipro Corporation
    • B. Braun SE
    • AngioDynamics, Inc.
    • Teleflex Incorporated
    • Poly Medicure Ltd.
    • BL Group of Companies

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
    • 3.3.1. Moderate bargaining power of suppliers
    • 3.3.2. Moderate threat of new entrants
    • 3.3.3. Moderate threat of substitutes
    • 3.3.4. Moderate intensity of rivalry
    • 3.3.5. Moderate bargaining power of buyers
  • 3.4. Market dynamics
    • 3.4.1. Drivers
      • 3.4.1.1. Rise in prevalence of chronic diseases
      • 3.4.1.2. Surge in number of surgical procedures
      • 3.4.1.3. Technological advancements in intravenous equipment
    • 3.4.2. Restraints
      • 3.4.2.1. Risk of complications
    • 3.4.3. Opportunities
      • 3.4.3.1. Growth opportunities in emerging countries

CHAPTER 4: IV CATHETERS MARKET, BY PRODUCT

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. 18G
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. 20G
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country
  • 4.4. 22G
    • 4.4.1. Key market trends, growth factors and opportunities
    • 4.4.2. Market size and forecast, by region
    • 4.4.3. Market share analysis by country
  • 4.5. 24G
    • 4.5.1. Key market trends, growth factors and opportunities
    • 4.5.2. Market size and forecast, by region
    • 4.5.3. Market share analysis by country
  • 4.6. Others
    • 4.6.1. Key market trends, growth factors and opportunities
    • 4.6.2. Market size and forecast, by region
    • 4.6.3. Market share analysis by country

CHAPTER 5: IV CATHETERS MARKET, BY TYPE

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Peripheral IV Catheters
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Central Venous Catheters
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country
  • 5.4. Others
    • 5.4.1. Key market trends, growth factors and opportunities
    • 5.4.2. Market size and forecast, by region
    • 5.4.3. Market share analysis by country

CHAPTER 6: IV CATHETERS MARKET, BY END USER

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. Hospitals
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by region
    • 6.2.3. Market share analysis by country
  • 6.3. Ambulatory Surgical Centers
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by region
    • 6.3.3. Market share analysis by country
  • 6.4. Others
    • 6.4.1. Key market trends, growth factors and opportunities
    • 6.4.2. Market size and forecast, by region
    • 6.4.3. Market share analysis by country

CHAPTER 7: IV CATHETERS MARKET, BY REGION

  • 7.1. Overview
    • 7.1.1. Market size and forecast By Region
  • 7.2. North America
    • 7.2.1. Key market trends, growth factors and opportunities
    • 7.2.2. Market size and forecast, by Product
    • 7.2.3. Market size and forecast, by Type
    • 7.2.4. Market size and forecast, by End User
    • 7.2.5. Market size and forecast, by country
      • 7.2.5.1. U.S.
      • 7.2.5.1.1. Market size and forecast, by Product
      • 7.2.5.1.2. Market size and forecast, by Type
      • 7.2.5.1.3. Market size and forecast, by End User
      • 7.2.5.2. Canada
      • 7.2.5.2.1. Market size and forecast, by Product
      • 7.2.5.2.2. Market size and forecast, by Type
      • 7.2.5.2.3. Market size and forecast, by End User
      • 7.2.5.3. Mexico
      • 7.2.5.3.1. Market size and forecast, by Product
      • 7.2.5.3.2. Market size and forecast, by Type
      • 7.2.5.3.3. Market size and forecast, by End User
  • 7.3. Europe
    • 7.3.1. Key market trends, growth factors and opportunities
    • 7.3.2. Market size and forecast, by Product
    • 7.3.3. Market size and forecast, by Type
    • 7.3.4. Market size and forecast, by End User
    • 7.3.5. Market size and forecast, by country
      • 7.3.5.1. Germany
      • 7.3.5.1.1. Market size and forecast, by Product
      • 7.3.5.1.2. Market size and forecast, by Type
      • 7.3.5.1.3. Market size and forecast, by End User
      • 7.3.5.2. France
      • 7.3.5.2.1. Market size and forecast, by Product
      • 7.3.5.2.2. Market size and forecast, by Type
      • 7.3.5.2.3. Market size and forecast, by End User
      • 7.3.5.3. UK
      • 7.3.5.3.1. Market size and forecast, by Product
      • 7.3.5.3.2. Market size and forecast, by Type
      • 7.3.5.3.3. Market size and forecast, by End User
      • 7.3.5.4. Italy
      • 7.3.5.4.1. Market size and forecast, by Product
      • 7.3.5.4.2. Market size and forecast, by Type
      • 7.3.5.4.3. Market size and forecast, by End User
      • 7.3.5.5. Spain
      • 7.3.5.5.1. Market size and forecast, by Product
      • 7.3.5.5.2. Market size and forecast, by Type
      • 7.3.5.5.3. Market size and forecast, by End User
      • 7.3.5.6. Rest of Europe
      • 7.3.5.6.1. Market size and forecast, by Product
      • 7.3.5.6.2. Market size and forecast, by Type
      • 7.3.5.6.3. Market size and forecast, by End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key market trends, growth factors and opportunities
    • 7.4.2. Market size and forecast, by Product
    • 7.4.3. Market size and forecast, by Type
    • 7.4.4. Market size and forecast, by End User
    • 7.4.5. Market size and forecast, by country
      • 7.4.5.1. Japan
      • 7.4.5.1.1. Market size and forecast, by Product
      • 7.4.5.1.2. Market size and forecast, by Type
      • 7.4.5.1.3. Market size and forecast, by End User
      • 7.4.5.2. China
      • 7.4.5.2.1. Market size and forecast, by Product
      • 7.4.5.2.2. Market size and forecast, by Type
      • 7.4.5.2.3. Market size and forecast, by End User
      • 7.4.5.3. India
      • 7.4.5.3.1. Market size and forecast, by Product
      • 7.4.5.3.2. Market size and forecast, by Type
      • 7.4.5.3.3. Market size and forecast, by End User
      • 7.4.5.4. Australia
      • 7.4.5.4.1. Market size and forecast, by Product
      • 7.4.5.4.2. Market size and forecast, by Type
      • 7.4.5.4.3. Market size and forecast, by End User
      • 7.4.5.5. South Korea
      • 7.4.5.5.1. Market size and forecast, by Product
      • 7.4.5.5.2. Market size and forecast, by Type
      • 7.4.5.5.3. Market size and forecast, by End User
      • 7.4.5.6. Malaysia
      • 7.4.5.6.1. Market size and forecast, by Product
      • 7.4.5.6.2. Market size and forecast, by Type
      • 7.4.5.6.3. Market size and forecast, by End User
      • 7.4.5.7. Thailand
      • 7.4.5.7.1. Market size and forecast, by Product
      • 7.4.5.7.2. Market size and forecast, by Type
      • 7.4.5.7.3. Market size and forecast, by End User
      • 7.4.5.8. Philippines
      • 7.4.5.8.1. Market size and forecast, by Product
      • 7.4.5.8.2. Market size and forecast, by Type
      • 7.4.5.8.3. Market size and forecast, by End User
      • 7.4.5.9. Singapore
      • 7.4.5.9.1. Market size and forecast, by Product
      • 7.4.5.9.2. Market size and forecast, by Type
      • 7.4.5.9.3. Market size and forecast, by End User
      • 7.4.5.10. Indonesia
      • 7.4.5.10.1. Market size and forecast, by Product
      • 7.4.5.10.2. Market size and forecast, by Type
      • 7.4.5.10.3. Market size and forecast, by End User
      • 7.4.5.11. Vietnam
      • 7.4.5.11.1. Market size and forecast, by Product
      • 7.4.5.11.2. Market size and forecast, by Type
      • 7.4.5.11.3. Market size and forecast, by End User
      • 7.4.5.12. Rest of Asia-Pacific
      • 7.4.5.12.1. Market size and forecast, by Product
      • 7.4.5.12.2. Market size and forecast, by Type
      • 7.4.5.12.3. Market size and forecast, by End User
  • 7.5. LAMEA
    • 7.5.1. Key market trends, growth factors and opportunities
    • 7.5.2. Market size and forecast, by Product
    • 7.5.3. Market size and forecast, by Type
    • 7.5.4. Market size and forecast, by End User
    • 7.5.5. Market size and forecast, by country
      • 7.5.5.1. Brazil
      • 7.5.5.1.1. Market size and forecast, by Product
      • 7.5.5.1.2. Market size and forecast, by Type
      • 7.5.5.1.3. Market size and forecast, by End User
      • 7.5.5.2. Saudi Arabia
      • 7.5.5.2.1. Market size and forecast, by Product
      • 7.5.5.2.2. Market size and forecast, by Type
      • 7.5.5.2.3. Market size and forecast, by End User
      • 7.5.5.3. South Africa
      • 7.5.5.3.1. Market size and forecast, by Product
      • 7.5.5.3.2. Market size and forecast, by Type
      • 7.5.5.3.3. Market size and forecast, by End User
      • 7.5.5.4. Rest of LAMEA
      • 7.5.5.4.1. Market size and forecast, by Product
      • 7.5.5.4.2. Market size and forecast, by Type
      • 7.5.5.4.3. Market size and forecast, by End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product mapping of top 10 player
  • 8.4. Competitive dashboard
  • 8.5. Competitive heatmap
  • 8.6. Top player positioning, 2022

CHAPTER 9: COMPANY PROFILES

  • 9.1. AngioDynamics, Inc.
    • 9.1.1. Company overview
    • 9.1.2. Key executives
    • 9.1.3. Company snapshot
    • 9.1.4. Operating business segments
    • 9.1.5. Product portfolio
    • 9.1.6. Business performance
  • 9.2. Terumo Corporation
    • 9.2.1. Company overview
    • 9.2.2. Key executives
    • 9.2.3. Company snapshot
    • 9.2.4. Operating business segments
    • 9.2.5. Product portfolio
    • 9.2.6. Business performance
    • 9.2.7. Key strategic moves and developments
  • 9.3. Teleflex Incorporated
    • 9.3.1. Company overview
    • 9.3.2. Key executives
    • 9.3.3. Company snapshot
    • 9.3.4. Operating business segments
    • 9.3.5. Product portfolio
    • 9.3.6. Business performance
    • 9.3.7. Key strategic moves and developments
  • 9.4. ICU Medical Inc.
    • 9.4.1. Company overview
    • 9.4.2. Key executives
    • 9.4.3. Company snapshot
    • 9.4.4. Operating business segments
    • 9.4.5. Product portfolio
    • 9.4.6. Business performance
    • 9.4.7. Key strategic moves and developments
  • 9.5. Becton, Dickinson and Company
    • 9.5.1. Company overview
    • 9.5.2. Key executives
    • 9.5.3. Company snapshot
    • 9.5.4. Operating business segments
    • 9.5.5. Product portfolio
    • 9.5.6. Business performance
  • 9.6. B. Braun SE
    • 9.6.1. Company overview
    • 9.6.2. Key executives
    • 9.6.3. Company snapshot
    • 9.6.4. Operating business segments
    • 9.6.5. Product portfolio
    • 9.6.6. Business performance
    • 9.6.7. Key strategic moves and developments
  • 9.7. BL Group of Companies
    • 9.7.1. Company overview
    • 9.7.2. Key executives
    • 9.7.3. Company snapshot
    • 9.7.4. Operating business segments
    • 9.7.5. Product portfolio
  • 9.8. Poly Medicure Ltd.
    • 9.8.1. Company overview
    • 9.8.2. Key executives
    • 9.8.3. Company snapshot
    • 9.8.4. Operating business segments
    • 9.8.5. Product portfolio
    • 9.8.6. Business performance
  • 9.9. Vygon
    • 9.9.1. Company overview
    • 9.9.2. Key executives
    • 9.9.3. Company snapshot
    • 9.9.4. Operating business segments
    • 9.9.5. Product portfolio
  • 9.10. Nipro Corporation
    • 9.10.1. Company overview
    • 9.10.2. Key executives
    • 9.10.3. Company snapshot
    • 9.10.4. Operating business segments
    • 9.10.5. Product portfolio
    • 9.10.6. Business performance
    • 9.10.7. Key strategic moves and developments

LIST OF TABLES

  • TABLE 01. GLOBAL IV CATHETERS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 02. IV CATHETERS MARKET FOR 18G, BY REGION, 2022-2032 ($MILLION)
  • TABLE 03. IV CATHETERS MARKET FOR 20G, BY REGION, 2022-2032 ($MILLION)
  • TABLE 04. IV CATHETERS MARKET FOR 22G, BY REGION, 2022-2032 ($MILLION)
  • TABLE 05. IV CATHETERS MARKET FOR 24G, BY REGION, 2022-2032 ($MILLION)
  • TABLE 06. IV CATHETERS MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 07. GLOBAL IV CATHETERS MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 08. IV CATHETERS MARKET FOR PERIPHERAL IV CATHETERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 09. IV CATHETERS MARKET FOR CENTRAL VENOUS CATHETERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 10. IV CATHETERS MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 11. GLOBAL IV CATHETERS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 12. IV CATHETERS MARKET FOR HOSPITALS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 13. IV CATHETERS MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 14. IV CATHETERS MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 15. IV CATHETERS MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 16. NORTH AMERICA IV CATHETERS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 17. NORTH AMERICA IV CATHETERS MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 18. NORTH AMERICA IV CATHETERS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 19. NORTH AMERICA IV CATHETERS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 20. U.S. IV CATHETERS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 21. U.S. IV CATHETERS MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 22. U.S. IV CATHETERS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 23. CANADA IV CATHETERS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 24. CANADA IV CATHETERS MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 25. CANADA IV CATHETERS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 26. MEXICO IV CATHETERS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 27. MEXICO IV CATHETERS MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 28. MEXICO IV CATHETERS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 29. EUROPE IV CATHETERS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 30. EUROPE IV CATHETERS MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 31. EUROPE IV CATHETERS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 32. EUROPE IV CATHETERS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 33. GERMANY IV CATHETERS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 34. GERMANY IV CATHETERS MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 35. GERMANY IV CATHETERS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 36. FRANCE IV CATHETERS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 37. FRANCE IV CATHETERS MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 38. FRANCE IV CATHETERS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 39. UK IV CATHETERS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 40. UK IV CATHETERS MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 41. UK IV CATHETERS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 42. ITALY IV CATHETERS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 43. ITALY IV CATHETERS MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 44. ITALY IV CATHETERS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 45. SPAIN IV CATHETERS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 46. SPAIN IV CATHETERS MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 47. SPAIN IV CATHETERS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 48. REST OF EUROPE IV CATHETERS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 49. REST OF EUROPE IV CATHETERS MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 50. REST OF EUROPE IV CATHETERS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 51. ASIA-PACIFIC IV CATHETERS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 52. ASIA-PACIFIC IV CATHETERS MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 53. ASIA-PACIFIC IV CATHETERS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 54. ASIA-PACIFIC IV CATHETERS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 55. JAPAN IV CATHETERS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 56. JAPAN IV CATHETERS MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 57. JAPAN IV CATHETERS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 58. CHINA IV CATHETERS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 59. CHINA IV CATHETERS MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 60. CHINA IV CATHETERS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 61. INDIA IV CATHETERS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 62. INDIA IV CATHETERS MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 63. INDIA IV CATHETERS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 64. AUSTRALIA IV CATHETERS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 65. AUSTRALIA IV CATHETERS MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 66. AUSTRALIA IV CATHETERS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 67. SOUTH KOREA IV CATHETERS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 68. SOUTH KOREA IV CATHETERS MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 69. SOUTH KOREA IV CATHETERS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 70. MALAYSIA IV CATHETERS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 71. MALAYSIA IV CATHETERS MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 72. MALAYSIA IV CATHETERS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 73. THAILAND IV CATHETERS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 74. THAILAND IV CATHETERS MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 75. THAILAND IV CATHETERS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 76. PHILIPPINES IV CATHETERS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 77. PHILIPPINES IV CATHETERS MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 78. PHILIPPINES IV CATHETERS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 79. SINGAPORE IV CATHETERS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 80. SINGAPORE IV CATHETERS MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 81. SINGAPORE IV CATHETERS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 82. INDONESIA IV CATHETERS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 83. INDONESIA IV CATHETERS MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 84. INDONESIA IV CATHETERS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 85. VIETNAM IV CATHETERS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 86. VIETNAM IV CATHETERS MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 87. VIETNAM IV CATHETERS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 88. REST OF ASIA-PACIFIC IV CATHETERS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 89. REST OF ASIA-PACIFIC IV CATHETERS MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 90. REST OF ASIA-PACIFIC IV CATHETERS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 91. LAMEA IV CATHETERS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 92. LAMEA IV CATHETERS MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 93. LAMEA IV CATHETERS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 94. LAMEA IV CATHETERS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 95. BRAZIL IV CATHETERS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 96. BRAZIL IV CATHETERS MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 97. BRAZIL IV CATHETERS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 98. SAUDI ARABIA IV CATHETERS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 99. SAUDI ARABIA IV CATHETERS MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 100. SAUDI ARABIA IV CATHETERS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 101. SOUTH AFRICA IV CATHETERS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 102. SOUTH AFRICA IV CATHETERS MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 103. SOUTH AFRICA IV CATHETERS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 104. REST OF LAMEA IV CATHETERS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 105. REST OF LAMEA IV CATHETERS MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 106. REST OF LAMEA IV CATHETERS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 107. ANGIODYNAMICS, INC.: KEY EXECUTIVES
  • TABLE 108. ANGIODYNAMICS, INC.: COMPANY SNAPSHOT
  • TABLE 109. ANGIODYNAMICS, INC.: PRODUCT SEGMENTS
  • TABLE 110. ANGIODYNAMICS, INC.: PRODUCT PORTFOLIO
  • TABLE 111. TERUMO CORPORATION: KEY EXECUTIVES
  • TABLE 112. TERUMO CORPORATION: COMPANY SNAPSHOT
  • TABLE 113. TERUMO CORPORATION: PRODUCT SEGMENTS
  • TABLE 114. TERUMO CORPORATION: PRODUCT PORTFOLIO
  • TABLE 115. TERUMO CORPORATION: KEY STRATERGIES
  • TABLE 116. TELEFLEX INCORPORATED: KEY EXECUTIVES
  • TABLE 117. TELEFLEX INCORPORATED: COMPANY SNAPSHOT
  • TABLE 118. TELEFLEX INCORPORATED: PRODUCT SEGMENTS
  • TABLE 119. TELEFLEX INCORPORATED: PRODUCT PORTFOLIO
  • TABLE 120. TELEFLEX INCORPORATED: KEY STRATERGIES
  • TABLE 121. ICU MEDICAL INC.: KEY EXECUTIVES
  • TABLE 122. ICU MEDICAL INC.: COMPANY SNAPSHOT
  • TABLE 123. ICU MEDICAL INC.: PRODUCT SEGMENTS
  • TABLE 124. ICU MEDICAL INC.: PRODUCT PORTFOLIO
  • TABLE 125. ICU MEDICAL INC.: KEY STRATERGIES
  • TABLE 126. BECTON, DICKINSON AND COMPANY: KEY EXECUTIVES
  • TABLE 127. BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
  • TABLE 128. BECTON, DICKINSON AND COMPANY: PRODUCT SEGMENTS
  • TABLE 129. BECTON, DICKINSON AND COMPANY: PRODUCT PORTFOLIO
  • TABLE 130. B. BRAUN SE: KEY EXECUTIVES
  • TABLE 131. B. BRAUN SE: COMPANY SNAPSHOT
  • TABLE 132. B. BRAUN SE: PRODUCT SEGMENTS
  • TABLE 133. B. BRAUN SE: PRODUCT PORTFOLIO
  • TABLE 134. B. BRAUN SE: KEY STRATERGIES
  • TABLE 135. BL GROUP OF COMPANIES: KEY EXECUTIVES
  • TABLE 136. BL GROUP OF COMPANIES: COMPANY SNAPSHOT
  • TABLE 137. BL GROUP OF COMPANIES: PRODUCT SEGMENTS
  • TABLE 138. BL GROUP OF COMPANIES: PRODUCT PORTFOLIO
  • TABLE 139. POLY MEDICURE LTD.: KEY EXECUTIVES
  • TABLE 140. POLY MEDICURE LTD.: COMPANY SNAPSHOT
  • TABLE 141. POLY MEDICURE LTD.: PRODUCT SEGMENTS
  • TABLE 142. POLY MEDICURE LTD.: PRODUCT PORTFOLIO
  • TABLE 143. VYGON: KEY EXECUTIVES
  • TABLE 144. VYGON: COMPANY SNAPSHOT
  • TABLE 145. VYGON: PRODUCT SEGMENTS
  • TABLE 146. VYGON: PRODUCT PORTFOLIO
  • TABLE 147. NIPRO CORPORATION: KEY EXECUTIVES
  • TABLE 148. NIPRO CORPORATION: COMPANY SNAPSHOT
  • TABLE 149. NIPRO CORPORATION: PRODUCT SEGMENTS
  • TABLE 150. NIPRO CORPORATION: PRODUCT PORTFOLIO
  • TABLE 151. NIPRO CORPORATION: KEY STRATERGIES

LIST OF FIGURES

  • FIGURE 01. IV CATHETERS MARKET, 2022-2032
  • FIGURE 02. SEGMENTATION OF IV CATHETERS MARKET,2022-2032
  • FIGURE 03. TOP IMPACTING FACTORS IN IV CATHETERS MARKET (2022 TO 2032)
  • FIGURE 04. TOP INVESTMENT POCKETS IN IV CATHETERS MARKET (2023-2032)
  • FIGURE 05. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 06. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 07. MODERATE THREAT OF SUBSTITUTES
  • FIGURE 08. MODERATE INTENSITY OF RIVALRY
  • FIGURE 09. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 10. GLOBAL IV CATHETERS MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 11. IV CATHETERS MARKET, BY PRODUCT, 2022 AND 2032(%)
  • FIGURE 12. COMPARATIVE SHARE ANALYSIS OF IV CATHETERS MARKET FOR 18G, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 13. COMPARATIVE SHARE ANALYSIS OF IV CATHETERS MARKET FOR 20G, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 14. COMPARATIVE SHARE ANALYSIS OF IV CATHETERS MARKET FOR 22G, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 15. COMPARATIVE SHARE ANALYSIS OF IV CATHETERS MARKET FOR 24G, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 16. COMPARATIVE SHARE ANALYSIS OF IV CATHETERS MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 17. IV CATHETERS MARKET, BY TYPE, 2022 AND 2032(%)
  • FIGURE 18. COMPARATIVE SHARE ANALYSIS OF IV CATHETERS MARKET FOR PERIPHERAL IV CATHETERS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 19. COMPARATIVE SHARE ANALYSIS OF IV CATHETERS MARKET FOR CENTRAL VENOUS CATHETERS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 20. COMPARATIVE SHARE ANALYSIS OF IV CATHETERS MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 21. IV CATHETERS MARKET, BY END USER, 2022 AND 2032(%)
  • FIGURE 22. COMPARATIVE SHARE ANALYSIS OF IV CATHETERS MARKET FOR HOSPITALS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 23. COMPARATIVE SHARE ANALYSIS OF IV CATHETERS MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 24. COMPARATIVE SHARE ANALYSIS OF IV CATHETERS MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 25. IV CATHETERS MARKET BY REGION, 2022 AND 2032(%)
  • FIGURE 26. U.S. IV CATHETERS MARKET, 2022-2032 ($MILLION)
  • FIGURE 27. CANADA IV CATHETERS MARKET, 2022-2032 ($MILLION)
  • FIGURE 28. MEXICO IV CATHETERS MARKET, 2022-2032 ($MILLION)
  • FIGURE 29. GERMANY IV CATHETERS MARKET, 2022-2032 ($MILLION)
  • FIGURE 30. FRANCE IV CATHETERS MARKET, 2022-2032 ($MILLION)
  • FIGURE 31. UK IV CATHETERS MARKET, 2022-2032 ($MILLION)
  • FIGURE 32. ITALY IV CATHETERS MARKET, 2022-2032 ($MILLION)
  • FIGURE 33. SPAIN IV CATHETERS MARKET, 2022-2032 ($MILLION)
  • FIGURE 34. REST OF EUROPE IV CATHETERS MARKET, 2022-2032 ($MILLION)
  • FIGURE 35. JAPAN IV CATHETERS MARKET, 2022-2032 ($MILLION)
  • FIGURE 36. CHINA IV CATHETERS MARKET, 2022-2032 ($MILLION)
  • FIGURE 37. INDIA IV CATHETERS MARKET, 2022-2032 ($MILLION)
  • FIGURE 38. AUSTRALIA IV CATHETERS MARKET, 2022-2032 ($MILLION)
  • FIGURE 39. SOUTH KOREA IV CATHETERS MARKET, 2022-2032 ($MILLION)
  • FIGURE 40. MALAYSIA IV CATHETERS MARKET, 2022-2032 ($MILLION)
  • FIGURE 41. THAILAND IV CATHETERS MARKET, 2022-2032 ($MILLION)
  • FIGURE 42. PHILIPPINES IV CATHETERS MARKET, 2022-2032 ($MILLION)
  • FIGURE 43. SINGAPORE IV CATHETERS MARKET, 2022-2032 ($MILLION)
  • FIGURE 44. INDONESIA IV CATHETERS MARKET, 2022-2032 ($MILLION)
  • FIGURE 45. VIETNAM IV CATHETERS MARKET, 2022-2032 ($MILLION)
  • FIGURE 46. REST OF ASIA-PACIFIC IV CATHETERS MARKET, 2022-2032 ($MILLION)
  • FIGURE 47. BRAZIL IV CATHETERS MARKET, 2022-2032 ($MILLION)
  • FIGURE 48. SAUDI ARABIA IV CATHETERS MARKET, 2022-2032 ($MILLION)
  • FIGURE 49. SOUTH AFRICA IV CATHETERS MARKET, 2022-2032 ($MILLION)
  • FIGURE 50. REST OF LAMEA IV CATHETERS MARKET, 2022-2032 ($MILLION)
  • FIGURE 51. TOP WINNING STRATEGIES, BY YEAR (2020-2022)
  • FIGURE 52. TOP WINNING STRATEGIES, BY DEVELOPMENT (2020-2022)
  • FIGURE 53. TOP WINNING STRATEGIES, BY COMPANY (2020-2022)
  • FIGURE 54. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 55. COMPETITIVE DASHBOARD
  • FIGURE 56. COMPETITIVE HEATMAP: IV CATHETERS MARKET
  • FIGURE 57. TOP PLAYER POSITIONING, 2022
  • FIGURE 58. ANGIODYNAMICS, INC.: NET SALES, 2021-2023 ($MILLION)
  • FIGURE 59. ANGIODYNAMICS, INC.: REVENUE SHARE BY SEGMENT, 2023 (%)
  • FIGURE 60. ANGIODYNAMICS, INC.: REVENUE SHARE BY REGION, 2023 (%)
  • FIGURE 61. TERUMO CORPORATION: NET SALES, 2021-2023 ($MILLION)
  • FIGURE 62. TERUMO CORPORATION: REVENUE SHARE BY SEGMENT, 2023 (%)
  • FIGURE 63. TERUMO CORPORATION: REVENUE SHARE BY REGION, 2023 (%)
  • FIGURE 64. TELEFLEX INCORPORATED: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 65. TELEFLEX INCORPORATED: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 66. ICU MEDICAL INC.: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 67. ICU MEDICAL INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 68. ICU MEDICAL INC.: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 69. BECTON, DICKINSON AND COMPANY: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 70. BECTON, DICKINSON AND COMPANY: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 71. BECTON, DICKINSON AND COMPANY: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 72. B. BRAUN SE: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 73. B. BRAUN SE: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 74. B. BRAUN SE: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 75. POLY MEDICURE LTD.: NET REVENUE, 2021-2023 ($MILLION)
  • FIGURE 76. NIPRO CORPORATION: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 77. NIPRO CORPORATION: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 78. NIPRO CORPORATION: REVENUE SHARE BY REGION, 2022 (%)